Contact Info
Office of Medical Cannabis
651-201-5598
844-879-3381 (toll-free)
Anxiety Disorder Review
Background Report on Published Research, Interviews, and Work Group
Since 2016, anxiety disorder or panic disorder has been petitioned to be added as a qualifying condition for medical cannabis during the annual petition process.
Each petition had been denied due to lack of clinical evidence and the desire to avoid any unintended consequences. At the conclusion of the 2020 petition cycle, the Commissioner of Health requested the Office of Medical Cannabis take a more in-depth look at the issue.
A three-pronged approach was initiated to evaluate the impact of adding or not adding anxiety disorder to the list of qualifying medical conditions for medical cannabis.
The approach included:
- A review of the current literature and research.
- Interviews with states that have added or denied anxiety disorder as a qualifying condition.
- A work group of professionals with expertise in anxiety disorder to obtain their perspectives and opinions.
Download the final Anxiety Disorder Review (PDF)
- Learn more about the project's background and approach, the literature and research review, experience of other states, and information on the work group of health care professionals that was convened.